Gastroenterology
Cell therapies for inflammatory bowel and liver diseases
Inflammatory bowel diseases (Crohn's disease, ulcerative colitis) and chronic liver diseases affect millions of people worldwide. MSC cell therapies offer an innovative approach to treating these conditions through immune response modulation and promotion of intestinal mucosa and liver tissue regeneration.
Clinical studies have shown that local and systemic MSC cell application in Crohn's disease reduces inflammation, promotes fistula healing, and extends remission periods. In liver diseases, MSC cells help reduce fibrosis and support hepatocyte regeneration.
GaiaCell is developing specialized MSC preparations for gastroenterological indications, including local applications for perianal fistulae in Crohn's disease. Our protocols are based on the latest clinical evidence and EU ATMP standards.
Clinical Evidence & Statistics
Fistula healing in Crohn's disease
EU-approved therapy (Alofisel)
Reduction in liver fibrosis
Want to Learn More?
Fill out our questionnaire or contact us for a free consultation about MSC therapy options for your condition.
